Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| TScan Therapeutics, Inc.(TCRX) | 630,000 | 630,000 | 0 | $630.0K | $617.5K | 49.27% | -$12.5K |
| Barinthus Biotherapeutics PlADS | 642,204 | 642,204 | 0 | $365.4K | $423.9K | 33.82% | +$58.4K |
| Werewolf Therapeutics, Inc.(HOWL) | 589,102 | 589,102 | 0 | $490.5K | $212.0K | 16.92% | -$278.5K |